These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 25425133)
1. Determining the cost of obesity and its common comorbidities from a commercial claims database. Padula WV; Allen RR; Nair KV Clin Obes; 2014 Feb; 4(1):53-8. PubMed ID: 25425133 [TBL] [Abstract][Full Text] [Related]
2. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis. Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139 [TBL] [Abstract][Full Text] [Related]
3. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US. Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211 [TBL] [Abstract][Full Text] [Related]
4. Real-world burden of comorbidities in US patients with psoriasis. Shah K; Mellars L; Changolkar A; Feldman SR J Am Acad Dermatol; 2017 Aug; 77(2):287-292.e4. PubMed ID: 28623046 [TBL] [Abstract][Full Text] [Related]
5. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Asche CV; Joish VN; Camacho F; Drake CL Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965 [TBL] [Abstract][Full Text] [Related]
7. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus. Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736 [TBL] [Abstract][Full Text] [Related]
8. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States. Fu AZ; Jhaveri M J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589 [TBL] [Abstract][Full Text] [Related]
9. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791 [TBL] [Abstract][Full Text] [Related]
10. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887 [TBL] [Abstract][Full Text] [Related]
11. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Lin PJ; Kent DM; Winn A; Cohen JT; Neumann PJ Am J Manag Care; 2015 Jan; 21(1):e23-34. PubMed ID: 25880265 [TBL] [Abstract][Full Text] [Related]
12. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods. Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613 [TBL] [Abstract][Full Text] [Related]
13. Healthcare use by veterans treated for diabetes mellitus in the Veterans Affairs medical care system. Ashton CM; Septimus J; Petersen NJ; Souchek J; Menke TJ; Collins TC; Wray NP Am J Manag Care; 2003 Feb; 9(2):145-50. PubMed ID: 12597602 [TBL] [Abstract][Full Text] [Related]
14. Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults. Park C; Fang J; Hawkins NA; Wang G Am J Prev Med; 2017 Dec; 53(6S2):S172-S181. PubMed ID: 29153118 [TBL] [Abstract][Full Text] [Related]
15. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis]. Wolfenstetter SB Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820 [TBL] [Abstract][Full Text] [Related]
16. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States. Durden E; Walker D; Gray S; Fowler R; Juneau P; Gooch K Neurourol Urodyn; 2018 Jun; 37(5):1641-1649. PubMed ID: 29464813 [TBL] [Abstract][Full Text] [Related]
17. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204 [TBL] [Abstract][Full Text] [Related]
18. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
19. Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study. Nickel KB; Wallace AE; Warren DK; Ball KE; Mines D; Fraser VJ; Olsen MA BMC Health Serv Res; 2016 Aug; 16(a):388. PubMed ID: 27527888 [TBL] [Abstract][Full Text] [Related]
20. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Zhao Y; Ye W; Boye KS; Holcombe JH; Swindle R Diabet Med; 2009 Jan; 26(1):61-9. PubMed ID: 19125762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]